Advanced Enzyme Technologies Ltd
Audited Financials Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026
RESULTS
◆ Monitor Closely
LOW RISK
📅 Filed on BSE: 09 May 2026, 01:45 PM IST · BSE ID: 27bae9e9-7771-4e4e-bb68-f94fc105c6ae
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its yearly financial results and proposed paying shareholders a final dividend of ₹1.35 per share.
🤖 AI Summary
- Board approved Audited Financial Results (Standalone and Consolidated) for FY26 and Q4 FY26.
- Recommended a Final Dividend of ₹1.35 per Equity Share (67.5% on face value ₹2) for FY26.
- Deferred interim dividend to preserve capital for evaluating strategic avenues and corporate actions.
- Approved re-appointment of Mr. Mukund Madhusudan Kabra as Whole Time Director for 5 years.
- Approved appointment of Mr. Pradip Bhailal Shah as Additional Independent Director for 5 years.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
₹ 1.35/-
Final Dividend % on Face Value
67.5%
ESOP Equity Shares Allotted
49,350 Equity Shares
Paid-up Share Capital (before allotment)
₹ 22,38,53,600
Paid-up Share Capital (after allotment)
₹ 22,39,52,300
Total Equity Shares (after allotment)
11,19,76,150 Equity Shares
🏢 How This Affects the Company
The deferral of an interim dividend indicates management's intent to retain capital, potentially for future strategic growth initiatives or corporate actions, which could alter the company's business scope or market position.
The recommended final dividend of ₹1.35 per equity share will result in a cash outflow upon shareholder approval and payment. The allotment of 49,350 Equity Shares increases the company's paid-up share capital from ₹22,38,53,600 to ₹22,39,52,300.
Re-appointment of Mr. Mukund Madhusudan Kabra as Whole Time Director ensures continuity in leadership and operational oversight for another five-year term. The appointment of Mr. Pradip Bhailal Shah as an Additional Independent Director diversifies the Board's composition and governance structure.
The decision to defer an interim dividend to preserve capital for strategic avenues introduces a degree of uncertainty regarding the nature and timing of these potential corporate actions. Shareholders await further details on these strategic considerations.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must approve the recommended Final Dividend at the 37th Annual General Meeting.
👤
Who Is Affected
Shareholders holding equity shares before the yet-to-be-announced record date will be entitled to the Final Dividend of ₹1.35 per Equity Share upon approval.
🔍
Management Signal
Management intends to preserve capital for evaluating potential strategic avenues and corporate actions to maximize long-term shareholder value, deferring immediate interim dividend distribution.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Record date announcement for the Final Dividend entitlement.
Date of the 37th Annual General Meeting for dividend and director approvals.
Further intimation from the company regarding strategic avenues or corporate actions.
LOW RISK
The filing reports routine approvals and dividend recommendation, with management signaling strategic capital use, not immediate risks.
💡 Investor Takeaway
The Board approved FY26 financial results and recommended a final dividend of ₹1.35 per equity share. An interim dividend was deferred to preserve capital for evaluating strategic avenues. Allotment of 49,350 ESOP shares increased paid-up capital to ₹22,39,52,300.
⚖️ Strengths & Concerns
✅ Positives
- Board recommended a Final Dividend of ₹1.35 per Equity Share for FY26, signaling shareholder returns.
- Re-appointment of Whole Time Director Mr. Mukund Madhusudan Kabra ensures continuity in leadership.
- Auditors issued an unmodified opinion on the Audited Financial Results for FY26.
⚠️ Concerns
- The Board decided to defer the declaration of an interim dividend, impacting immediate shareholder cash returns.
- Reasons for deferring interim dividend, while strategic, introduce uncertainty regarding future corporate actions.
📅 Company Track Record
No previous filings or specific historical data for Advanced Enzyme Technologies Ltd were found in the provided context to establish trends for comparison. The company was incorporated in 1989.
Based on publicly available historical data. For context only.